nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM2—Dimenhydrinate—atopic dermatitis	0.542	0.672	CbGbCtD
Methylscopolamine bromide—CHRM2—Diphenhydramine—atopic dermatitis	0.265	0.328	CbGbCtD
Methylscopolamine bromide—Drowsiness—Diphenhydramine—atopic dermatitis	0.00303	0.0172	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Dimenhydrinate—atopic dermatitis	0.00303	0.0172	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Loratadine—atopic dermatitis	0.00234	0.0132	CcSEcCtD
Methylscopolamine bromide—Tension—Dimenhydrinate—atopic dermatitis	0.00233	0.0132	CcSEcCtD
Methylscopolamine bromide—Tension—Diphenhydramine—atopic dermatitis	0.00233	0.0132	CcSEcCtD
Methylscopolamine bromide—Nervousness—Dimenhydrinate—atopic dermatitis	0.0023	0.013	CcSEcCtD
Methylscopolamine bromide—Nervousness—Diphenhydramine—atopic dermatitis	0.0023	0.013	CcSEcCtD
Methylscopolamine bromide—Mydriasis—Prednisolone—atopic dermatitis	0.00228	0.0129	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Dimenhydrinate—atopic dermatitis	0.00223	0.0126	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Diphenhydramine—atopic dermatitis	0.00223	0.0126	CcSEcCtD
Methylscopolamine bromide—Palpitations—Dimenhydrinate—atopic dermatitis	0.0021	0.0118	CcSEcCtD
Methylscopolamine bromide—Palpitations—Diphenhydramine—atopic dermatitis	0.0021	0.0118	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Diphenhydramine—atopic dermatitis	0.00197	0.0112	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Dimenhydrinate—atopic dermatitis	0.00197	0.0112	CcSEcCtD
Methylscopolamine bromide—Confusional state—Dimenhydrinate—atopic dermatitis	0.00195	0.011	CcSEcCtD
Methylscopolamine bromide—Confusional state—Diphenhydramine—atopic dermatitis	0.00195	0.011	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00189	0.0107	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Diphenhydramine—atopic dermatitis	0.00189	0.0107	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Pimecrolimus—atopic dermatitis	0.00187	0.0106	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Tacrolimus—atopic dermatitis	0.0018	0.0102	CcSEcCtD
Methylscopolamine bromide—Tension—Loratadine—atopic dermatitis	0.00179	0.0101	CcSEcCtD
Methylscopolamine bromide—Nervousness—Loratadine—atopic dermatitis	0.00177	0.01	CcSEcCtD
Methylscopolamine bromide—Insomnia—Diphenhydramine—atopic dermatitis	0.00175	0.00989	CcSEcCtD
Methylscopolamine bromide—Insomnia—Dimenhydrinate—atopic dermatitis	0.00175	0.00989	CcSEcCtD
Methylscopolamine bromide—Somnolence—Diphenhydramine—atopic dermatitis	0.00172	0.00972	CcSEcCtD
Methylscopolamine bromide—Somnolence—Dimenhydrinate—atopic dermatitis	0.00172	0.00972	CcSEcCtD
Methylscopolamine bromide—Headache—Desonide—atopic dermatitis	0.00166	0.00938	CcSEcCtD
Methylscopolamine bromide—Constipation—Dimenhydrinate—atopic dermatitis	0.00165	0.00935	CcSEcCtD
Methylscopolamine bromide—Constipation—Diphenhydramine—atopic dermatitis	0.00165	0.00935	CcSEcCtD
Methylscopolamine bromide—Palpitations—Loratadine—atopic dermatitis	0.00161	0.00912	CcSEcCtD
Methylscopolamine bromide—Constipation—Pimecrolimus—atopic dermatitis	0.0016	0.00905	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.00159	0.00901	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.00159	0.00901	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Fluocinonide—atopic dermatitis	0.00158	0.00894	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.00155	0.00874	CcSEcCtD
Methylscopolamine bromide—Urticaria—Dimenhydrinate—atopic dermatitis	0.00154	0.00869	CcSEcCtD
Methylscopolamine bromide—Urticaria—Diphenhydramine—atopic dermatitis	0.00154	0.00869	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Loratadine—atopic dermatitis	0.00152	0.0086	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Loratadine—atopic dermatitis	0.00149	0.00842	CcSEcCtD
Methylscopolamine bromide—Urticaria—Pimecrolimus—atopic dermatitis	0.00149	0.0084	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Loratadine—atopic dermatitis	0.00145	0.00822	CcSEcCtD
Methylscopolamine bromide—Dizziness—Fluocinonide—atopic dermatitis	0.00142	0.00802	CcSEcCtD
Methylscopolamine bromide—Asthenia—Diphenhydramine—atopic dermatitis	0.00139	0.00785	CcSEcCtD
Methylscopolamine bromide—Asthenia—Dimenhydrinate—atopic dermatitis	0.00139	0.00785	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.00138	0.00779	CcSEcCtD
Methylscopolamine bromide—Insomnia—Loratadine—atopic dermatitis	0.00135	0.00762	CcSEcCtD
Methylscopolamine bromide—Headache—Fluocinonide—atopic dermatitis	0.00134	0.0076	CcSEcCtD
Methylscopolamine bromide—Somnolence—Loratadine—atopic dermatitis	0.00132	0.00749	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Mometasone—atopic dermatitis	0.0013	0.00738	CcSEcCtD
Methylscopolamine bromide—Dizziness—Dimenhydrinate—atopic dermatitis	0.00128	0.00723	CcSEcCtD
Methylscopolamine bromide—Dizziness—Diphenhydramine—atopic dermatitis	0.00128	0.00723	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Mometasone—atopic dermatitis	0.00128	0.00723	CcSEcCtD
Methylscopolamine bromide—Constipation—Loratadine—atopic dermatitis	0.00127	0.0072	CcSEcCtD
Methylscopolamine bromide—Vomiting—Dimenhydrinate—atopic dermatitis	0.00123	0.00696	CcSEcCtD
Methylscopolamine bromide—Vomiting—Diphenhydramine—atopic dermatitis	0.00123	0.00696	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Loratadine—atopic dermatitis	0.00123	0.00694	CcSEcCtD
Methylscopolamine bromide—Tension—Tacrolimus—atopic dermatitis	0.00122	0.00692	CcSEcCtD
Methylscopolamine bromide—Headache—Dimenhydrinate—atopic dermatitis	0.00121	0.00685	CcSEcCtD
Methylscopolamine bromide—Headache—Diphenhydramine—atopic dermatitis	0.00121	0.00685	CcSEcCtD
Methylscopolamine bromide—Nervousness—Tacrolimus—atopic dermatitis	0.00121	0.00685	CcSEcCtD
Methylscopolamine bromide—Vomiting—Pimecrolimus—atopic dermatitis	0.00119	0.00673	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Tacrolimus—atopic dermatitis	0.00118	0.00664	CcSEcCtD
Methylscopolamine bromide—Headache—Pimecrolimus—atopic dermatitis	0.00117	0.00663	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Prednisolone—atopic dermatitis	0.00115	0.00651	CcSEcCtD
Methylscopolamine bromide—Nausea—Dimenhydrinate—atopic dermatitis	0.00115	0.0065	CcSEcCtD
Methylscopolamine bromide—Nausea—Diphenhydramine—atopic dermatitis	0.00115	0.0065	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Hydrocortisone—atopic dermatitis	0.00112	0.00635	CcSEcCtD
Methylscopolamine bromide—Nausea—Pimecrolimus—atopic dermatitis	0.00111	0.00628	CcSEcCtD
Methylscopolamine bromide—Palpitations—Tacrolimus—atopic dermatitis	0.0011	0.00623	CcSEcCtD
Methylscopolamine bromide—Asthenia—Loratadine—atopic dermatitis	0.00107	0.00604	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Triamcinolone—atopic dermatitis	0.00106	0.00598	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Methylprednisolone—atopic dermatitis	0.00106	0.00597	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Tacrolimus—atopic dermatitis	0.00104	0.00587	CcSEcCtD
Methylscopolamine bromide—Confusional state—Tacrolimus—atopic dermatitis	0.00103	0.0058	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.00102	0.00575	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Tacrolimus—atopic dermatitis	0.000993	0.00562	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000987	0.00558	CcSEcCtD
Methylscopolamine bromide—Dizziness—Loratadine—atopic dermatitis	0.000985	0.00557	CcSEcCtD
Methylscopolamine bromide—Vomiting—Loratadine—atopic dermatitis	0.000947	0.00536	CcSEcCtD
Methylscopolamine bromide—Headache—Loratadine—atopic dermatitis	0.000934	0.00528	CcSEcCtD
Methylscopolamine bromide—Insomnia—Tacrolimus—atopic dermatitis	0.000921	0.0052	CcSEcCtD
Methylscopolamine bromide—Asthenia—Mometasone—atopic dermatitis	0.000918	0.00519	CcSEcCtD
Methylscopolamine bromide—Somnolence—Tacrolimus—atopic dermatitis	0.000905	0.00512	CcSEcCtD
Methylscopolamine bromide—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000886	0.00501	CcSEcCtD
Methylscopolamine bromide—Nausea—Loratadine—atopic dermatitis	0.000885	0.005	CcSEcCtD
Methylscopolamine bromide—Constipation—Tacrolimus—atopic dermatitis	0.00087	0.00492	CcSEcCtD
Methylscopolamine bromide—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000852	0.00481	CcSEcCtD
Methylscopolamine bromide—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000839	0.00474	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000839	0.00474	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Prednisone—atopic dermatitis	0.000836	0.00473	CcSEcCtD
Methylscopolamine bromide—Vomiting—Mometasone—atopic dermatitis	0.000813	0.0046	CcSEcCtD
Methylscopolamine bromide—Urticaria—Tacrolimus—atopic dermatitis	0.000809	0.00457	CcSEcCtD
Methylscopolamine bromide—Headache—Mometasone—atopic dermatitis	0.000801	0.00453	CcSEcCtD
Methylscopolamine bromide—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000795	0.0045	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Prednisone—atopic dermatitis	0.000765	0.00433	CcSEcCtD
Methylscopolamine bromide—Nausea—Mometasone—atopic dermatitis	0.00076	0.00429	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisolone—atopic dermatitis	0.000751	0.00424	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00075	0.00424	CcSEcCtD
Methylscopolamine bromide—Asthenia—Tacrolimus—atopic dermatitis	0.00073	0.00413	CcSEcCtD
Methylscopolamine bromide—Dizziness—Tacrolimus—atopic dermatitis	0.000673	0.00381	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisolone—atopic dermatitis	0.00065	0.00368	CcSEcCtD
Methylscopolamine bromide—Vomiting—Tacrolimus—atopic dermatitis	0.000647	0.00366	CcSEcCtD
Methylscopolamine bromide—Headache—Tacrolimus—atopic dermatitis	0.000638	0.0036	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000635	0.00359	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisolone—atopic dermatitis	0.000634	0.00359	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Hydrocortisone—atopic dermatitis	0.00062	0.0035	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Triamcinolone—atopic dermatitis	0.00061	0.00345	CcSEcCtD
Methylscopolamine bromide—Nausea—Tacrolimus—atopic dermatitis	0.000605	0.00342	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methylprednisolone—atopic dermatitis	0.000601	0.0034	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000598	0.00338	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000597	0.00337	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisolone—atopic dermatitis	0.000588	0.00332	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Triamcinolone—atopic dermatitis	0.000583	0.0033	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Methylprednisolone—atopic dermatitis	0.000582	0.00329	CcSEcCtD
Methylscopolamine bromide—Insomnia—Hydrocortisone—atopic dermatitis	0.000574	0.00325	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisone—atopic dermatitis	0.000546	0.00308	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000542	0.00307	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000542	0.00307	CcSEcCtD
Methylscopolamine bromide—Insomnia—Triamcinolone—atopic dermatitis	0.000541	0.00306	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methylprednisolone—atopic dermatitis	0.00054	0.00305	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisolone—atopic dermatitis	0.000536	0.00303	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Dexamethasone—atopic dermatitis	0.000529	0.00299	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Betamethasone—atopic dermatitis	0.000529	0.00299	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000523	0.00296	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisolone—atopic dermatitis	0.000516	0.00292	CcSEcCtD
Methylscopolamine bromide—Urticaria—Hydrocortisone—atopic dermatitis	0.000504	0.00285	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000493	0.00279	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000492	0.00278	CcSEcCtD
Methylscopolamine bromide—Insomnia—Betamethasone—atopic dermatitis	0.000491	0.00277	CcSEcCtD
Methylscopolamine bromide—Insomnia—Dexamethasone—atopic dermatitis	0.000491	0.00277	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisolone—atopic dermatitis	0.000479	0.00271	CcSEcCtD
Methylscopolamine bromide—Urticaria—Triamcinolone—atopic dermatitis	0.000475	0.00269	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methylprednisolone—atopic dermatitis	0.000474	0.00268	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisone—atopic dermatitis	0.000472	0.00267	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000468	0.00264	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisone—atopic dermatitis	0.000461	0.00261	CcSEcCtD
Methylscopolamine bromide—Asthenia—Hydrocortisone—atopic dermatitis	0.000456	0.00258	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000447	0.00253	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Betamethasone—atopic dermatitis	0.000447	0.00253	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Triamcinolone—atopic dermatitis	0.00044	0.00249	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000439	0.00248	CcSEcCtD
Methylscopolamine bromide—Urticaria—Dexamethasone—atopic dermatitis	0.000431	0.00244	CcSEcCtD
Methylscopolamine bromide—Urticaria—Betamethasone—atopic dermatitis	0.000431	0.00244	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisolone—atopic dermatitis	0.00043	0.00243	CcSEcCtD
Methylscopolamine bromide—Asthenia—Triamcinolone—atopic dermatitis	0.000429	0.00243	CcSEcCtD
Methylscopolamine bromide—Asthenia—Methylprednisolone—atopic dermatitis	0.000428	0.00242	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisone—atopic dermatitis	0.000427	0.00242	CcSEcCtD
Methylscopolamine bromide—Dizziness—Hydrocortisone—atopic dermatitis	0.00042	0.00237	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisolone—atopic dermatitis	0.000407	0.0023	CcSEcCtD
Methylscopolamine bromide—Constipation—Prednisone—atopic dermatitis	0.000404	0.00228	CcSEcCtD
Methylscopolamine bromide—Vomiting—Hydrocortisone—atopic dermatitis	0.000404	0.00228	CcSEcCtD
Methylscopolamine bromide—Headache—Hydrocortisone—atopic dermatitis	0.000398	0.00225	CcSEcCtD
Methylscopolamine bromide—Dizziness—Triamcinolone—atopic dermatitis	0.000395	0.00224	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methylprednisolone—atopic dermatitis	0.000394	0.00223	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisone—atopic dermatitis	0.000389	0.0022	CcSEcCtD
Methylscopolamine bromide—Asthenia—Betamethasone—atopic dermatitis	0.000389	0.0022	CcSEcCtD
Methylscopolamine bromide—Asthenia—Dexamethasone—atopic dermatitis	0.000389	0.0022	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisolone—atopic dermatitis	0.000386	0.00218	CcSEcCtD
Methylscopolamine bromide—Vomiting—Triamcinolone—atopic dermatitis	0.00038	0.00215	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methylprednisolone—atopic dermatitis	0.000379	0.00214	CcSEcCtD
Methylscopolamine bromide—Nausea—Hydrocortisone—atopic dermatitis	0.000377	0.00213	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisone—atopic dermatitis	0.000375	0.00212	CcSEcCtD
Methylscopolamine bromide—Headache—Triamcinolone—atopic dermatitis	0.000375	0.00212	CcSEcCtD
Methylscopolamine bromide—Headache—Methylprednisolone—atopic dermatitis	0.000374	0.00211	CcSEcCtD
Methylscopolamine bromide—Dizziness—Dexamethasone—atopic dermatitis	0.000359	0.00203	CcSEcCtD
Methylscopolamine bromide—Dizziness—Betamethasone—atopic dermatitis	0.000359	0.00203	CcSEcCtD
Methylscopolamine bromide—Nausea—Triamcinolone—atopic dermatitis	0.000355	0.00201	CcSEcCtD
Methylscopolamine bromide—Nausea—Methylprednisolone—atopic dermatitis	0.000354	0.002	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisone—atopic dermatitis	0.000348	0.00197	CcSEcCtD
Methylscopolamine bromide—Vomiting—Betamethasone—atopic dermatitis	0.000345	0.00195	CcSEcCtD
Methylscopolamine bromide—Vomiting—Dexamethasone—atopic dermatitis	0.000345	0.00195	CcSEcCtD
Methylscopolamine bromide—Headache—Dexamethasone—atopic dermatitis	0.00034	0.00192	CcSEcCtD
Methylscopolamine bromide—Headache—Betamethasone—atopic dermatitis	0.00034	0.00192	CcSEcCtD
Methylscopolamine bromide—Asthenia—Prednisone—atopic dermatitis	0.000339	0.00192	CcSEcCtD
Methylscopolamine bromide—Nausea—Dexamethasone—atopic dermatitis	0.000322	0.00182	CcSEcCtD
Methylscopolamine bromide—Nausea—Betamethasone—atopic dermatitis	0.000322	0.00182	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisone—atopic dermatitis	0.000312	0.00177	CcSEcCtD
Methylscopolamine bromide—Vomiting—Prednisone—atopic dermatitis	0.0003	0.0017	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisone—atopic dermatitis	0.000296	0.00167	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisone—atopic dermatitis	0.000281	0.00159	CcSEcCtD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL17—atopic dermatitis	6.34e-05	0.00391	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.84e-05	0.0036	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—CXCL10—atopic dermatitis	5.74e-05	0.00353	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CCR3—atopic dermatitis	5.72e-05	0.00352	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CCR3—atopic dermatitis	5.7e-05	0.00351	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—CCL5—atopic dermatitis	5.67e-05	0.00349	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CCR3—atopic dermatitis	5.65e-05	0.00348	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—PPARA—atopic dermatitis	5.62e-05	0.00346	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL22—atopic dermatitis	5.59e-05	0.00344	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL22—atopic dermatitis	5.57e-05	0.00343	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL22—atopic dermatitis	5.52e-05	0.0034	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCL27—atopic dermatitis	5.48e-05	0.00338	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCL27—atopic dermatitis	5.47e-05	0.00337	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCL27—atopic dermatitis	5.41e-05	0.00333	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	5.31e-05	0.00327	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	5.29e-05	0.00326	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	5.24e-05	0.00322	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL11—atopic dermatitis	5.11e-05	0.00315	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—CCR5—atopic dermatitis	5.11e-05	0.00315	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—TAC1—atopic dermatitis	5.1e-05	0.00314	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—NPS—atopic dermatitis	5.1e-05	0.00314	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—TAC1—atopic dermatitis	5.08e-05	0.00313	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—NPS—atopic dermatitis	5.08e-05	0.00313	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FCER2—atopic dermatitis	5.04e-05	0.0031	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—NPS—atopic dermatitis	5.03e-05	0.0031	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—TAC1—atopic dermatitis	5.03e-05	0.0031	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CXCR3—atopic dermatitis	5e-05	0.00308	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CXCR3—atopic dermatitis	4.98e-05	0.00307	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL27—atopic dermatitis	4.98e-05	0.00307	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL27—atopic dermatitis	4.96e-05	0.00306	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—CCL5—atopic dermatitis	4.94e-05	0.00304	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CXCR3—atopic dermatitis	4.93e-05	0.00304	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL27—atopic dermatitis	4.92e-05	0.00303	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	4.8e-05	0.00296	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	4.79e-05	0.00295	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	4.74e-05	0.00292	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL22—atopic dermatitis	4.69e-05	0.00289	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CCR3—atopic dermatitis	4.59e-05	0.00283	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	4.57e-05	0.00281	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	4.55e-05	0.0028	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	4.51e-05	0.00278	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL17—atopic dermatitis	4.47e-05	0.00275	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL17—atopic dermatitis	4.45e-05	0.00274	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—CCR5—atopic dermatitis	4.45e-05	0.00274	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL17—atopic dermatitis	4.41e-05	0.00271	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	4.29e-05	0.00264	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL27—atopic dermatitis	4.18e-05	0.00257	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCR3—atopic dermatitis	4.17e-05	0.00257	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.11e-05	0.00253	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	4.11e-05	0.00253	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.1e-05	0.00253	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—TAC1—atopic dermatitis	4.09e-05	0.00252	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—NPS—atopic dermatitis	4.09e-05	0.00252	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	4.06e-05	0.0025	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	4.04e-05	0.00249	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	4.03e-05	0.00248	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCR3—atopic dermatitis	4.01e-05	0.00247	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	3.99e-05	0.00246	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—IL5—atopic dermatitis	3.8e-05	0.00234	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL17—atopic dermatitis	3.75e-05	0.00231	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—TAC1—atopic dermatitis	3.72e-05	0.00229	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—NPS—atopic dermatitis	3.72e-05	0.00229	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCR3—atopic dermatitis	3.64e-05	0.00224	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	3.6e-05	0.00222	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	3.59e-05	0.00221	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	3.55e-05	0.00219	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	3.55e-05	0.00219	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	3.54e-05	0.00218	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.53e-05	0.00218	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	3.5e-05	0.00216	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	3.48e-05	0.00214	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	3.47e-05	0.00213	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL5—atopic dermatitis	3.45e-05	0.00213	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	3.43e-05	0.00211	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GLB1—atopic dermatitis	3.35e-05	0.00206	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KIF3A—atopic dermatitis	3.34e-05	0.00206	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	3.3e-05	0.00203	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	3.29e-05	0.00203	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	3.26e-05	0.00201	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCL10—atopic dermatitis	3.24e-05	0.002	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	3.23e-05	0.00199	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	3.22e-05	0.00198	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ADSL—atopic dermatitis	3.21e-05	0.00197	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	3.19e-05	0.00196	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	3.13e-05	0.00193	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	3.12e-05	0.00192	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	3.12e-05	0.00192	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	3.09e-05	0.0019	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	3.09e-05	0.0019	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL11—atopic dermatitis	3.02e-05	0.00186	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CMA1—atopic dermatitis	3.02e-05	0.00186	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.98e-05	0.00184	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	2.94e-05	0.00181	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	2.94e-05	0.00181	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	2.93e-05	0.00181	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	2.93e-05	0.00181	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	2.93e-05	0.0018	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	2.9e-05	0.00179	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	2.9e-05	0.00178	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	2.88e-05	0.00177	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	2.88e-05	0.00177	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	2.87e-05	0.00177	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	2.87e-05	0.00177	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	2.84e-05	0.00175	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	2.84e-05	0.00175	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	2.84e-05	0.00175	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	2.82e-05	0.00174	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	2.82e-05	0.00173	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	2.79e-05	0.00172	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	2.79e-05	0.00172	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	2.69e-05	0.00166	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.68e-05	0.00165	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	2.68e-05	0.00165	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	2.67e-05	0.00164	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	2.64e-05	0.00163	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	2.64e-05	0.00162	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	2.63e-05	0.00162	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	2.62e-05	0.00161	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	2.62e-05	0.00161	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	2.61e-05	0.00161	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	2.61e-05	0.00161	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	2.6e-05	0.0016	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	2.58e-05	0.00159	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	2.58e-05	0.00159	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	2.57e-05	0.00158	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	2.56e-05	0.00157	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	2.54e-05	0.00156	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	2.53e-05	0.00156	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	2.51e-05	0.00155	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.49e-05	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.48e-05	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	2.46e-05	0.00152	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.46e-05	0.00151	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	2.43e-05	0.0015	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	2.42e-05	0.00149	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.41e-05	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	2.4e-05	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	2.35e-05	0.00145	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	2.34e-05	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	2.32e-05	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	2.28e-05	0.00141	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	2.28e-05	0.00141	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	2.28e-05	0.0014	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	2.25e-05	0.00139	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NPS—atopic dermatitis	2.19e-05	0.00135	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	2.19e-05	0.00135	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	2.15e-05	0.00133	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	2.13e-05	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	2.13e-05	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	2.12e-05	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	2.12e-05	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	2.1e-05	0.00129	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	2.1e-05	0.00129	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	2.07e-05	0.00128	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	2.07e-05	0.00127	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	2.05e-05	0.00126	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL5—atopic dermatitis	2.04e-05	0.00126	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	2e-05	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	1.99e-05	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	1.99e-05	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	1.97e-05	0.00122	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	1.97e-05	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	1.96e-05	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	1.94e-05	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	1.89e-05	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	1.89e-05	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.89e-05	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.88e-05	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	1.87e-05	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	1.78e-05	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	1.78e-05	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	1.77e-05	0.00109	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	1.77e-05	0.00109	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	1.76e-05	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	1.75e-05	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	1.74e-05	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	1.73e-05	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	1.73e-05	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	1.71e-05	0.00105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	1.61e-05	0.00099	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	1.6e-05	0.000987	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	1.59e-05	0.000977	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	1.55e-05	0.000951	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NPS—atopic dermatitis	1.55e-05	0.000951	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	1.54e-05	0.000948	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NPS—atopic dermatitis	1.54e-05	0.000948	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	1.53e-05	0.000939	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NPS—atopic dermatitis	1.53e-05	0.000939	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	1.52e-05	0.000936	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	1.52e-05	0.000933	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	1.51e-05	0.00093	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	1.5e-05	0.000922	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	1.5e-05	0.000921	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	1.45e-05	0.000895	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL5—atopic dermatitis	1.44e-05	0.000884	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL5—atopic dermatitis	1.43e-05	0.000882	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL5—atopic dermatitis	1.42e-05	0.000873	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NGF—atopic dermatitis	1.39e-05	0.000854	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	1.38e-05	0.00085	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	1.35e-05	0.000831	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	1.32e-05	0.000812	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	1.22e-05	0.000754	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	1.22e-05	0.000752	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	1.21e-05	0.000744	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	1.14e-05	0.000704	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARA—atopic dermatitis	1.09e-05	0.000668	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.07e-05	0.000659	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.07e-05	0.000657	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.06e-05	0.000651	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	1.05e-05	0.000649	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	1.05e-05	0.000647	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	1.04e-05	0.000641	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	1.02e-05	0.00063	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	1.02e-05	0.000628	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	1.01e-05	0.000622	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NGF—atopic dermatitis	9.77e-06	0.000601	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NGF—atopic dermatitis	9.73e-06	0.000599	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	9.72e-06	0.000599	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	9.69e-06	0.000597	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NGF—atopic dermatitis	9.64e-06	0.000593	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	9.6e-06	0.000591	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	9.5e-06	0.000585	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	9.47e-06	0.000583	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	9.38e-06	0.000577	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	9.29e-06	0.000572	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	9.26e-06	0.00057	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	9.17e-06	0.000565	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	8.16e-06	0.000502	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	8.05e-06	0.000496	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	8.03e-06	0.000494	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	7.95e-06	0.000489	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL2—atopic dermatitis	7.8e-06	0.00048	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	7.76e-06	0.000478	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	7.17e-06	0.000442	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	5.74e-06	0.000354	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	5.72e-06	0.000352	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	5.67e-06	0.000349	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL2—atopic dermatitis	5.49e-06	0.000338	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL2—atopic dermatitis	5.47e-06	0.000337	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	5.46e-06	0.000336	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	5.44e-06	0.000335	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL2—atopic dermatitis	5.42e-06	0.000334	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	5.39e-06	0.000332	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	5.05e-06	0.000311	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	5.04e-06	0.00031	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	4.99e-06	0.000307	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—atopic dermatitis	4.58e-06	0.000282	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—atopic dermatitis	3.23e-06	0.000199	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—atopic dermatitis	3.22e-06	0.000198	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—atopic dermatitis	3.18e-06	0.000196	CbGpPWpGaD
